Provided by Tiger Trade Technology Pte. Ltd.

Precision Biosciences Inc

6.80
+0.37005.75%
Volume:105.68K
Turnover:701.07K
Market Cap:187.69M
PE:-2.43
High:6.83
Open:6.43
Low:6.40
Close:6.43
52wk High:9.62
52wk Low:3.53
Shares:27.60M
Float Shares:25.26M
Volume Ratio:1.31
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8007
EPS(LYR):-3.5649
ROE:-135.15%
ROA:-19.37%
PB:4.14
PE(LYR):-1.91

Loading ...

Precision BioSciences (DTIL) Receives a Buy from H.C. Wainwright

TIPRANKS
·
May 22

Precision BioSciences reports new Phase 1 ELIMINATE-B biopsy data for PBGENE-HBV at EASL 2026

Reuters
·
May 21

Analyst Forecasts For Precision BioSciences, Inc. (NASDAQ:DTIL) Are Surging Higher

Simply Wall St.
·
May 13

Analysts’ Top Healthcare Picks: Precision BioSciences (DTIL), Nuvectis Pharma (NVCT)

TIPRANKS
·
May 07

Precision Bio Q1 sales beat, helped by milestone revenue

Reuters
·
May 05

Precision BioSciences Q1 EPS $(0.75) Misses $(0.66) Estimate, Sales $10.838M Beat $4.050M Estimate

Benzinga Earnings
·
May 05

BRIEF-Precision BioSciences, Inc. Q1 Revenue USD 10.838 Million Vs. IBES Estimate USD 4.05 Million

Reuters
·
May 05

Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 05

Precision BioSciences, Inc. Q1 Net Income USD -18.441 Million

THOMSON REUTERS
·
May 05

Precision BioSciences Set to Announce First-Quarter Results Amid Market Focus on Revenue

Deep News
·
May 05

Precision BioSciences Inc expected to post a loss of 65 cents a share - Earnings Preview

Reuters
·
May 01

Precision BioSciences updates financial calendar, sets first-quarter results release and business update

Reuters
·
Apr 30

Press Release: Precision BioSciences to Report First Quarter 2026 Financial Results on May 5, 2026

Dow Jones
·
Apr 30

Precision BioSciences starts patient enrollment in Phase 1/2 FUNCTION-DMD study

Reuters
·
Apr 29

Precision BioSciences Activates First Clinical Trial Site and Begins Patient Enrollment in Phase 1/2 Function-Dmd Study

THOMSON REUTERS
·
Apr 29

H.C. Wainwright Reaffirms Their Buy Rating on Precision BioSciences (DTIL)

TIPRANKS
·
Apr 29

Precision BioSciences to give ASGCT oral presentation on PBGENE-DMD preclinical data

Reuters
·
Apr 28

Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (Asgct) 2026 Annual Meeting

THOMSON REUTERS
·
Apr 28

Precision BioSciences announces grant of inducement awards

TIPRANKS
·
Apr 24

Precision BioSciences grants 7,094 inducement RSUs to new employee

Reuters
·
Apr 24